Virtus Investment Advisers, Inc. Tg Therapeutics, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 11,892 shares of TGTX stock, worth $417,647. This represents 0.15% of its overall portfolio holdings.
Number of Shares
11,892
Previous 11,697
1.67%
Holding current value
$417,647
Previous $461,000
7.38%
% of portfolio
0.15%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
405Shares Held
91.9MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.8MShares$555 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$400 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$268 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$123 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$107 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.1B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...